TERM LOAN CREDIT AGREEMENT Dated as of June 8, 2018 among TAKEDA PHARMACEUTICAL COMPANY LIMITED, as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and JPMORGAN CHASE BANK, N.A., as Administrative Agent JPMORGAN CHASE BANK, N.A., SUMITOMO MITSUI...Term Loan Credit Agreement • December 6th, 2018 • Takeda Pharmaceutical Co LTD • Pharmaceutical preparations • New York
This Term Loan Credit Agreement (this “Agreement”) dated as of June 8, 2018 is among Takeda Pharmaceutical Company Limited, a joint-stock company organized and existing under the laws of Japan (the “Borrower”), the Lenders (as defined below) that are parties hereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (as defined below) for the Lenders.
AMENDMENT NO. 1 Dated as of June 8, 2018 to 364-DAY BRIDGE CREDIT AGREEMENT Dated as of May 8, 2018364-Day Bridge Credit Agreement • December 6th, 2018 • Takeda Pharmaceutical Co LTD • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 1 (this “Amendment”) is made as of June 8, 2018 by and among Takeda Pharmaceutical Company Limited, a joint-stock company organized and existing under the laws of Japan, (the “Company”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent”), under that certain 364-Day Bridge Credit Agreement dated as of May 8, 2018 by and among the Company, the Lenders and the Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Credit Agreement.
AMENDMENT NO. 2 Dated as of October 26, 2018 to 364-DAY BRIDGE CREDIT AGREEMENT Dated as of May 8, 2018364-Day Bridge Credit Agreement • December 6th, 2018 • Takeda Pharmaceutical Co LTD • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 2 (this “Amendment”) is made as of October 26, 2018 by and among Takeda Pharmaceutical Company Limited, a joint-stock company organized and existing under the laws of Japan, (the “Company”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent”), under that certain 364-Day Bridge Credit Agreement dated as of May 8, 2018 by and among the Company, the Lenders and the Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Credit Agreement.
TAKEDA PHARMACEUTICAL COMPANY LIMITED The Company MUFG Bank, Ltd. Fiscal Agent FISCAL AGENCY AGREEMENT Dated as of November 21, 2018 €1,250,000,000 0.375% Senior Notes due 2020 €1,000,000,000 Senior Floating Rate Notes due 2020 €1,500,000,000 1.125%...Fiscal Agency Agreement • December 6th, 2018 • Takeda Pharmaceutical Co LTD • Pharmaceutical preparations • New York
FISCAL AGENCY AGREEMENT, dated as of November 21, 2018, between Takeda Pharmaceutical Company Limited, a joint-stock corporation (kabushiki kaisha) organized under the laws of Japan (the “Company”), and MUFG Bank, Ltd., incorporated with limited liability in Japan, as fiscal agent (the “Fiscal Agent”).
